Evidence map›Paper›PMID 40583793›Full record

ArticleEuropean journal of neurology2025

Interpreting Addenbrooke's Cognitive Examination-III Scores in Dementia: Performance Distributions and Clinically Meaningful Change.

James Carrick, Sau Chi Cheung, David Foxe, Olivier Piguet

Abstract read
In one paragraph

Article in European journal of neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Efficacy ofJMIR research protocols · 2026
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

James CarrickSchool of Psychology, The University of Sydney, Sydney, Australia.ORCID 0000-0003-1392-8919
Sau Chi CheungSchool of Psychology, The University of Sydney, Sydney, Australia.ORCID 0000-0001-5370-7219
David FoxeSchool of Psychology, The University of Sydney, Sydney, Australia.ORCID 0000-0003-0299-3344
Olivier PiguetSchool of Psychology, The University of Sydney, Sydney, Australia.ORCID 0000-0002-6696-1440

Funding

Australian Research Council CE11000102National Health and Medical Research Council GNT1037746National Health and Medical Research Council GNT2008020
6 · The paper itself

Abstract

backgroundThe Addenbrooke's Cognitive Examination-III (ACE-III) is a common cognitive screening measure. We provide performance deciles, descriptive performance bands and indices of reliable change between repeat assessments using the ACE-III in a large cohort of dementia participants and healthy controls.

methodsBaseline data from 727 participants diagnosed with a dementia syndrome and 157 healthy controls were used to calculate performance deciles and descriptive bands. A subset of 393 participants diagnosed with a dementia syndrome completed two annual assessments. These data were used to calculate 95% confidence intervals of characteristic yearly change in each dementia syndrome. Data from a subset of 74 healthy participants who completed two assessments were used to calculate reliable change indices.

resultsBaseline performance was grouped into five descriptive performance bands across the entire spectrum of scores: Very Mild, Mild, Moderate, Severe and Very Severe. Deciles and performance bands are provided for all dementia participants combined, for each syndrome where n > 50, and for healthy controls, stratified by group, sex and years of education. A decline of -7 to -9 points yearly was characteristic for the dementia population, and this varied between syndromes. Reliable change calculations indicate that a 5-point decline from within the 'normal' range (88-100) is the minimum clinically important decline on the ACE-III.

conclusionsThis study presents a suite of reference data on the ACE-III in a range of dementia syndromes, providing important insight and support to clinicians who work with people living with cognitive impairments.

Indexed as

DementiaMental Status and Dementia TestsNeuropsychological TestsAgedAged, 80 and overCohort StudiesFemaleHumansMaleMiddle AgedAlzheimer's diseasecognitive screeningfrontotemporal dementianeurodegenerationprimary progressive aphasia

Identifiers

PMID40583793
PMCPMC12207243

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.